This page shows the latest linagliptin news and features for those working in and with pharma, biotech and healthcare.
Boehringer already has an existing relationship with Yuhan, which acts as the South Korean marketer for three of the German firm’s Eli Lilly-partnered diabetes therapies, Tradjenta (linagliptin), Trajenta Duo ... linagliptin/metformin) and Jardiance
Tradjenta (linagliptin) and metformin – and said yesterday the FDA had started its review of the Boehringer Ingelheim-partnered drug.
In particular, Eli Lilly-partnered diabetes franchise based on DPP-4 inhibitor Trajenta (linagliptin) climbed 23% to 1.1bn while sales of lung disease therapy Ofev (nintedanib) more than doubled to
It is the second combination of its type to be approved for marketing in the US after Eli Lilly and Boehringer Ingelheim's Glyxambi (linagliptin/empagliflozin).
Eli Lilly and Boehringer Ingelheim's Glyxambi (linagliptin/empagliflozin).
Sales of DPP-4 inhibitor Trajenta (linagliptin) and its Jentadueto (linagliptin and metformin) combination rose 42.9% to 909m.
More from news
Approximately 3 fully matching, plus 40 partially matching documents found.
Notable points are that despite the considerable promotion and, some would say, superior clinical data, none of the SGLT2s has exceeded Trajenta (linagliptin) - a 4th entrant DPP4 in sales.
This includes Germany-based Boehringer Ingelheim's disapproval of the generic comparator used in IQWiG's AMNOG assessment of the diabetes medicine Trajenta (linagliptin).
The G-BA had specified that linagliptin should be compared with a drug from the sulphonylurea class, such as glibenclamide or glimepiride. ... However, IQWiG was unable to infer any such benefit from the dossier because the manufacturers compared
Out of the 10 products assessed last year, four have obtained poor innovation scores: Esbriet (pirfenidone), Livazo (pitavastatin), Yellox (bromfenac) and Trajenta (linagliptin) and a majority of manufacturers have struggled – sometimes
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >300 healthcare communications professionals,...